Internal Medicine · Cullman, AL
NPI
1285821397
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
1890 Al Highway 157, Suite 300
Cullman, AL, 35058
Phone (256) 737-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$224K
8,871 services
Medicare patients, 2024
564
Average age 75
Drug cost, 2024
$2.4M
24,915 prescriptions
Company payments, 2025
$774
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeremy V Stidham was code 99490 (chronic, principal, and transitional care management), 633 times for 79 patients. In total Jeremy V Stidham billed 8,871 services in 137 codes, and Medicare paid $224K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 633 | 79 | $43.77 | $28K |
| 99214 Office E&M - Established | Office | 600 | 416 | $75.87 | $46K |
| 36415 Venipuncture Blood Collection | Office | 485 | 352 | $8.58 | $4,162 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 476 | 52 | $0.08 | $38.54 |
| 80053 Clinical Chemistry | Office | 393 | 325 | $10.29 | $4,046 |
| 80061 Clinical Chemistry | Office | 362 | 307 | $13.01 | $4,711 |
| 96372 Injection Administration | Office | 237 | 96 | $9.10 | $2,156 |
| 84443 Clinical Chemistry | Office | 213 | 179 | $16.41 | $3,494 |
| 83036 Blood Count | Office | 209 | 134 | $9.43 | $1,971 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 206 | 177 | $11.09 | $2,284 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 199 | 199 | $117.65 | $23K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 196 | 54 | $34.57 | $6,776 |
| 85025 Blood Count | Office | 194 | 167 | $7.58 | $1,470 |
| 82306 Clinical Chemistry | Office | 169 | 150 | $28.69 | $4,849 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 129 | 26 | $0.33 | $41.94 |
By year: 2022 $222K for 14,084 services; 2023 $281K for 11,839 services; 2024 $224K for 8,871 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 485 | 352 | $8.58 | $4,162 |
| 80053 Clinical Chemistry | 393 | 325 | $10.29 | $4,046 |
| 80061 Clinical Chemistry | 362 | 307 | $13.01 | $4,711 |
| 84443 Clinical Chemistry | 213 | 179 | $16.41 | $3,494 |
| 83036 Blood Count | 209 | 134 | $9.43 | $1,971 |
| 85025 Blood Count | 194 | 167 | $7.58 | $1,470 |
| 82306 Clinical Chemistry | 169 | 150 | $28.69 | $4,849 |
| 82607 Clinical Chemistry | 79 | 75 | $14.78 | $1,168 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 57 | 57 | $18.92 | $1,078 |
| 87804 Immunoassay | 44 | 22 | $15.58 | $686 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeremy V Stidham prescribed most often to Medicare patients was Levothyroxine Sodium, with 971 prescriptions and refills. In total Jeremy V Stidham wrote 24,915 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 971 | 2,496 | 259 | $15K |
| Gabapentin Generic | 819 | 1,328 | 175 | $13K |
| Tramadol Hcl Generic | 742 | 774 | 138 | $6,392 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 702 | 705 | 127 | $14K |
| Losartan Potassium Generic | 596 | 1,677 | 189 | $9,076 |
| Omeprazole Generic | 583 | 1,418 | 168 | $8,260 |
| Atorvastatin Calcium Generic | 562 | 1,537 | 179 | $8,812 |
| Montelukast Sodium Generic | 534 | 1,288 | 166 | $8,935 |
| Amlodipine Besylate Generic | 506 | 1,302 | 151 | $3,294 |
| Pantoprazole Sodium Generic | 462 | 1,164 | 136 | $6,475 |
| Pravastatin Sodium Generic | 410 | 1,129 | 122 | $8,443 |
| Trazodone Hcl Generic | 385 | 888 | 116 | $5,754 |
| Lisinopril Generic | 377 | 979 | 115 | $2,841 |
| Eliquis Apixaban | 377 | 518 | 68 | $292K |
| Furosemide Generic | 355 | 700 | 105 | $1,922 |
Brand drugs: 3,084 claims; generic drugs: 21,739 claims; opioid claims: 1,829.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeremy V Stidham $774 ($774 in general payments such as food, travel and fees) from 18 companies. The largest payer was Axsome Therapeutics, Inc. with $107.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 5 | $107 |
| Pfizer Inc. PFE | 5 | $92.72 |
| Abbvie Inc. ABBV | 4 | $62.95 |
| Corcept Therapeutics CORT | 3 | $62.24 |
| Harmony Biosciences LLC HRMY | 2 | $51.68 |
| Sanofi-Aventis U.S. LLC SNY | 2 | $46.18 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $45.8 |
| Lilly USA, LLC LLY | 3 | $44.42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37.54 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $37.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.